ABK PATENT ATTORNEYS
532
Patents represented
Technical areasPatents
Pharmaceuticals371
Medical technology80
Organic fine chemistry70
Biotechnology33
Macromolecular chemistry, polymers8

Countries of applicants

Summary

ABK PATENT ATTORNEYS is very experienced in the technologies „Pharmaceuticals“ and „Medical technology“. 82% of all patents are related to „(Bio)Chemistry“. Most important clients are „MONDOBIOTECH LABORATORIES AG“ and „BEVEC, Dorian“. ABK PATENT ATTORNEYS was very active in 2009 and 2013. Oftentimes, clients are from Germany.

Patents by year

Patents by area

3
Patent applications
81
Patent applications
438
Patent applications
6
Patent applications
2
Patent applications

Patents by applicant

RankNameCountryPatents
1MONDOBIOTECH LABORATORIES AGGermany162
2BEVEC, DORIANSwitzerland147
3MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.Germany56
4HEMOTEQ AGGermany18
5B. BRAUN AVITUM AGGermany14
6LEAD DISCOVERY CENTER GMBHGermany8
7EUROCOR GMBHGermany7
8B. BRAUN MELSUNGEN AGGermany6
9CARDIONOVUM GMBHPoland6
10ONCOTHERM KFT.Hungary6
11ZEDIRA GMBHGermany6
12KLOSS, HENNINGGermany5
13AXXIMA PHARMACEUTICALS AGGermany4
14MAGFORCE NANOTECHNOLOGIES AGGermany4
15MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K.Germany4
16SUSILO, RUDYGermany4
17TECHNISCHE UNIVERSITÄT DARMSTADTGermany4
18TROMMSDORFF GMBH & CO. KG ARZNEIMITTELGermany4
19BAYER INTELLECTUAL PROPERTY GMBHGermany3
20DIETZ, ULRICHGermany3
21DREI LILIEN PVG GMBH & CO. KGGermany3
22EVORIA GMBHGermany3
23GPC BIOTECH AGHungary3
24AICURIS GMBH & CO. KGGermany2
25AUDIOCURE PHARMA GMBHGermany2

Latest patents

Publication numberTitlePatent applicantYear
WO2016198170VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 5MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016198485UV-B ABSORBING COMPOUNDS ISOLATED FROM PLANTSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016193231METHOD TO DETECT ACTIVITY OF A POLYMERASELEAD DISCOVERY CENTER GMBH
MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016188972PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORSUNIVERSITEIT LEIDEN
2016
WO2016156338VACCINE AGAINST CARBAPENEM-RESISTANTMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016134741PROTEASOME SUBUNIT ACTIVITY ASSAYUNIVERSITEIT LEIDEN
2016
WO2016131789BENZOPYRROLIDONE DERIVATIVES POSSESSING ANTIVIRAL AND ANTICANCER PROPERTIESMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
VICHEM CHEMIE LTD.
2016
WO2016091399VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016087674PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLESEXCHANGE IMAGING TECHNOLOGIES GMBH
2016
WO2016075269USE OF A CITRATE SOLUTION FOR AFFINITY CHROMATOGRAPHIC PURIFICATION OF CRP USING PHOSPHOCHOLINE AND DERIVATIVES THEREOFPENTRACOR GMBH
2016
WO2016075339ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALINGNEUROVISION, INC.
2016
WO2016046420VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2016008603FOOD INTAKE, BODY WEIGHT AND GLUCOSE METABOLISM REGULATION BY MODULATION OF P2Y RECEPTOR SIGNALINGMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2016
WO2015193504SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVESPENTRACOR GMBH
2015
WO2015189433PYRIDAZINONES FOR THE TREATMENT OF CANCERMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2015
WO2015185516METHOD AND DEVICES FOR DE-EMULSIFYING AND COMPLEXING ORGANIC COMPOUNDS IN EMULSIONSDREI LILIEN PVG GMBH & CO. KG
2015
WO2015185675APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASESNANOSCIENCE FOR LIFE GMBH & COKG
2015
WO2015185676APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASESNANOSCIENCE FOR LIFE GMBH & COKG
WESTFALIA SEPARATOR AG
2015
WO2015181272RAB GERANYLGERANYL TRANSFERASE INHIBITORSLEAD DISCOVERY CENTER GMBH
MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2015
WO2015181341METHOD FOR REFINING LIPID PHASES, AND USEDREI LILIEN PVG GMBH & CO. KG
2015
WO2015181399METHOD FOR PURIFYING REFINED LIPID PHASESDREI LILIEN PVG GMBH & CO. KG
2015
WO2015177303DIAGNOSTIC FOR MODEL-BASED THERAPY PLANNING BACKGROUNDCYTOCENTRICS, INC., U.S.A.
2015
WO2015121468SCREENING ASSAY FOR GIBBERELLIN INHIBITORS OR ANALOGSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
EBERHARD-KARLS-UNIVERSITÄT TÜBINGEN UNIVERSITÄTSKLINIKUM
2015
WO2015114038SHAPE-ADAPTING ELECTRODE FOR ELECTROMAGNETIC ENERGY TRANSFERONCOTHERM KFT.
2015
WO2015110271DIAZABICYCLO[4.3.1]DECANE DERIVATIVES FOR TREATMENT OF PSYCHIATRIC DISORDERSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
2015
...